{
    "nctId": "NCT02997553",
    "briefTitle": "Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery",
    "officialTitle": "Reliability of Indocyanine Green Use in Sentinel Lymph Node Identification in Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma, Head and Neck Cancer, Melanoma (Skin), Squamous Cell Carcinoma, Skin, Cervix Cancer, Endometrium Cancer, Ovary Cancer, Vulva Cancer, Anus Cancer, Rectum Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 744,
    "primaryOutcomeMeasure": "Non-inferiority of indocyanine green guided sentinel lymph node biopsy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age \\>18 years\n* cancer histologically proved\n* patient eligible for sentinel node detection\n* contraceptive methods for men and women of childbearing age\n* signed informed consent form\n* patient affiliated to the social security system\n\nExclusion Criteria:\n\n* neoadjuvant chemotherapy or hormone therapy\n* adenopathy (s) clinically suspicious or positively cytopenic\n* women who are pregnant or breast-feeding\n* associated pathology that may prevent patient of receive indocyanine green\n* ongoing participation in another clinical trial with an investigational drug\n* patients deprived of liberty or under supervision\n* impossibility to undergo medical follow-up of the trial for geographical, social or psychological reasons",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}